The MCCC1 gene helps your body break down leucine, one of the building blocks of protein, so cells can use it for energy. If the MCCC1 gene does not work properly, breakdown products can build up and cause 3-methylcrotonyl-CoA carboxylase deficiency. Some people with pathogenic variants in this gene develop poor feeding, vomiting, low energy, low blood sugar, or developmental concerns, while others have few or no symptoms.
What is a gene?
A gene is a section of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for producing proteins, the parts of cells that do much of the work. Other genes mainly guide when certain processes happen, where they take place, and how strongly they operate. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. To go further into this topic, you can find more in the LearnHub.
Overview
MCCC1Gene function
What if the gene works
The MCCC1 gene helps your cells break down leucine, a building block of protein from food. This supports energy production and helps prevent certain breakdown products from building up.
Risk
What if the gene does not work
Variants in the MCCC1 gene can cause 3-methylcrotonyl-CoA carboxylase deficiency, which affects how the body breaks down protein. Milder to more severe variants may lead to no symptoms or to poor feeding, low energy, developmental differences, or metabolic illness.
Treatment
What does that mean for your treatment
Pathogenic variants in the MCCC1 gene can guide metabolic care rather than a gene targeted drug choice. Management may include avoiding fasting, using a sick day plan during illness, and sometimes carnitine supplements if levels are low; some people also benefit from adjusted leucine or overall protein intake.
Conditions associated with MCCC1
Gene function
What if the gene works
Your cells regularly turn parts of food into usable energy and smaller building blocks. Understanding what the MCCC1 gene does in the body helps explain one part of that process. It helps cells handle leucine, an amino acid from protein rich foods, inside mitochondria, the parts of cells that help make energy.
The MCCC1 gene helps cells process leucine, an amino acid your body gets from protein in food. It supports a step that changes a leucine byproduct into the next form so breakdown can continue.
By helping break down leucine in mitochondria, this gene supports how cells use nutrients for energy. This routine work is part of normal metabolism, which is how your body turns food into fuel and useful cell materials.
The protein made from the MCCC1 gene joins with the MCCC2 protein to form a working enzyme. It also relies on biotin, a B vitamin, to carry out this chemical step smoothly.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants have no noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant can change how a gene functions to a greater extent and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
MCCC1 gene variants can alter the protein’s shape, stability, or amount, so the enzyme complex may not assemble properly or work at full strength inside mitochondria. Some variants are milder and leave partial activity, while more disruptive changes, including variants that stop the protein early or disturb splicing, can leave little or no function. In 3-methylcrotonyl-CoA carboxylase deficiency, lower remaining activity may be linked to earlier or more noticeable features, although severity varies widely.
How variants are linked to conditions
Pathogenic variants in the MCCC1 gene cause 3-methylcrotonyl-CoA carboxylase deficiency, a rare inherited condition often picked up on newborn screening. This MCCC1 gene condition can look very different from one person to another. Some people stay well, while others may have feeding problems, vomiting, low energy, low blood sugar, or developmental concerns, especially during illness or long gaps without food.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely seen in the general population. Most do not have a direct effect on health and instead represent normal human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when more than one gene and environmental factors also contribute. In some situations, though, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For MCCC1, the main risk is inherited: a child is affected when both parents pass down a harmful variant in this gene. In people living with confirmed MCCC1-related disease, illness, long gaps without food, and sometimes a high-protein intake can make symptoms more likely or more severe.
Inheritance of MCCC1 variants
MCCC1-related 3-methylcrotonyl-CoA carboxylase deficiency is inherited in an autosomal recessive pattern. This means a child has to inherit two disease-causing variants in the MCCC1 gene, one from each parent, to have the condition. Parents who each carry one variant usually do not have symptoms. With each pregnancy, two carrier parents have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with no familial MCCC1 variant. Boys and girls are affected equally.
What does my MCCC1 result mean for my family?
For families with an MCCC1-related condition, close relatives may also be carriers, even if they feel completely well. Brothers and sisters could also be affected or be carriers, so family members sometimes choose to learn whether the gene change is present in them too. This kind of result usually matters most for siblings and for relatives planning children, because two carrier parents can pass the condition on to a child.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for MCCC1 variants usually uses a blood or saliva sample to read the MCCC1 gene and look for changes in its DNA code. This can help confirm whether someone carries one or two variants linked to 3-methylcrotonyl-CoA carboxylase deficiency, and it may also show whether parents are carriers.
When should I consider getting a genetic test?
Genetic testing for the MCCC1 gene may be considered after a newborn screening result that suggests 3-MCC deficiency, if there is a family history, or when a baby or child has poor feeding, vomiting, low blood sugar, or unusual sleepiness. It can help confirm the cause when this condition is suspected.
A genetic result is only one part of your health story
A genetic finding can provide valuable insight, but how much it explains varies based on the condition and the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, affect how the body functions over time. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. One person may break down a drug more slowly, while another may process it faster or be more sensitive to its effects. This helps explain why the same treatment can work well for some people, work less well for others, or cause more side effects in certain individuals.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It studies patterns between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. Understanding this can support treatment decisions that are more informed and more individualized. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the MCCC1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how people respond to medicines, so general questions about side effects, new symptoms, or whether a treatment is right for you are best discussed with your doctor.